SUPERSONIC SHEARWAVE ELASTOGRAPHY OF RESPONSE TO ANTI-CANCER THERAPY IN A XENOGRAFT TUMOR MODEL

被引:18
|
作者
Chamming's, Foucauld [1 ,2 ]
Le-Frere-Belda, Marie-Aude [3 ]
Latorre-Ossa, Heldmuth [4 ]
Fitoussi, Victor [1 ]
Redheuil, Alban [2 ]
Assayag, Franck [5 ]
Pidial, Laetitia [1 ]
Gennisson, Jean-Luc [4 ]
Tanter, Mickael [4 ]
Cuenod, Charles-Andre [1 ,2 ]
Fournier, Laure S. [1 ,2 ]
机构
[1] Univ Paris 05, Sorbonne Paris Cite, UMR S970, Cardiovasc Res Ctr PARCC, Paris, France
[2] Univ Paris 05, Hop Europeen Georges Pompidou, Assistance Publ Hop Paris, Dept Radiol,Sorbonne Paris Cite, Paris, France
[3] Univ Paris 05, Hop Europeen Georges Pompidou, Assistance Publ Hop Paris, Dept Pathol,Sorbonne Paris Cite, Paris, France
[4] Ecole Super Phys & Chim Ind Ville Paris, Inst Langevin Ondes & Images, Paris, France
[5] INSERM, U612, Pharmacol Preclin Antitumorale, Paris, France
来源
ULTRASOUND IN MEDICINE AND BIOLOGY | 2016年 / 42卷 / 04期
关键词
Shear wave elastography; Ultrasound; Stiffness changes; Breast cancer; Response to therapy; Pathology; ADVANCED BREAST-CANCER; NEOADJUVANT CHEMOTHERAPY; WAVE ELASTOGRAPHY; ULTRASOUND ELASTOGRAPHY; PATHOLOGICAL RESPONSE; CLINICAL-APPLICATION; EARLY PREDICTION; BIOMARKERS; CARCINOMA; DIAGNOSIS;
D O I
10.1016/j.ultrasmedbio.2015.12.001
中图分类号
O42 [声学];
学科分类号
070206 ; 082403 ;
摘要
Our objective was to determine if supersonic shear wave elastography (SSWE) can detect changes in stiffness of a breast cancer model under therapy. A human invasive carcinoma was implanted in 22 mice. Eleven were treated with an anti-angiogenic therapy and 11 with glucose for 24 d. Tumor volume and stiffness were assessed during 2 wk before treatment and 0, 7, 12, 20 and 24 d after the start of therapy using SSWE. Pathology was assessed after 12 and 24 d of treatment. We found that response to therapy was associated with early softening of treated tumors only, resulting in a significant difference from non-treated tumors after 12 d of treatment (p = 0.03). On pathology, large areas of necrosis were observed at 12 d in treated tumors. Although treatment was still effective, treated tumors subsequently stiffened during a second phase of the treatment (days 12-24), with a small amount of necrosis observed on pathology on day 24. In conclusion, SSWE was able to measure changes in the stiffness of tumors in response to anti-cancer treatment. However, stiffness changes associated with good response to treatment may change over time, and increased stiffness may also reflect therapy efficacy. (E-mail: foucauld.chammings@egp.aphp.fr) (C) 2016 World Federation for Ultrasound in Medicine & Biology.
引用
收藏
页码:924 / 930
页数:7
相关论文
共 50 条
  • [41] Hypertension after anti-cancer therapy
    Leitch, Victoria
    Ngo, Doan
    Sverdlov, Aaron
    HEART LUNG AND CIRCULATION, 2023, 32 (11): : 1407 - 1407
  • [42] Cold exposure as anti-cancer therapy
    Yuneva, Mariia
    CANCER CELL, 2022, 40 (10) : 1092 - 1094
  • [43] PEGylation in anti-cancer therapy: An overview
    Mishra, Prajna
    Nayak, Bismita
    Dey, R. K.
    ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 11 (03) : 337 - 348
  • [44] PEGylation in anti-cancer therapy: An overview
    Prajna Mishra
    Bismita Nayak
    R.K.Dey
    Asian Journal of Pharmaceutical Sciences, 2016, 11 (03) : 337 - 348
  • [45] Cellular Senescence and Anti-Cancer Therapy
    You, Jieqiong
    Dong, Rong
    Ying, Meidan
    He, Qiaojun
    Cao, Ji
    Yang, Bo
    CURRENT DRUG TARGETS, 2019, 20 (07) : 705 - 715
  • [46] Targeted anti-cancer therapy in the elderly
    Gonsalves, Wilson
    Ganti, Apar Kishor
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2011, 78 (03) : 227 - 242
  • [47] TRAIL as a target in anti-cancer therapy
    Wu, Gen Sheng
    CANCER LETTERS, 2009, 285 (01) : 1 - 5
  • [48] Lectins with Potential for Anti-Cancer Therapy
    Yau, Tammy
    Dan, Xiuli
    Ng, Charlene Cheuk Wing
    Ng, Tzi Bun
    MOLECULES, 2015, 20 (03): : 3791 - 3810
  • [49] Targeting mitosis for anti-cancer therapy
    Sudakin, Valery
    Yen, Timothy J.
    BIODRUGS, 2007, 21 (04) : 225 - 233
  • [50] PREDICTION OF RESPONSE TO ANTI-CANCER DRUGS
    FAVRE, R
    PIGNON, T
    MAROTIA, L
    SEITZ, JF
    DELPERO, JR
    GUERINEL, G
    CARCASSONNE, Y
    PRESSE MEDICALE, 1983, 12 (45): : 2875 - 2879